Page 50 - MI-1-1

Microbes & Immunity The feature of bladder cancer stem cells

doi: 10.1016/j.urology.2005.07.062 22. Lee TK, Guan XY, Ma S. Cancer stem cells in hepatocellular
carcinoma - from origin to clinical implications. Nat Rev
11. Maas M, Bedke J, Stenzl A, Todenhöfer T. Can
urinary biomarkers replace cystoscopy? World J Urol. Gastroenterol Hepatol. 2022;19(1):26-44.
2019;37(9):1741-1749. doi: 10.1038/s41575-021-00508-3
doi: 10.1007/s00345-018-2505-2 23. Butti R, Gunasekaran VP, Kumar TVS, Banerjee P,
Kundu GC. Breast cancer stem cells: Biology and therapeutic
12. Woldu SL, Bagrodia A, Lotan Y. Guideline of guidelines: Non-
muscle-invasive bladder cancer. BJU Int. 2017;119(3):371-380. implications. Int J Biochem Cell Biol. 2019;107:38-52.
doi: 10.1016/j.biocel.2018.12.001
doi: 10.1111/bju.13760
24. Gupta R, Bhatt LK, Johnston TP, Prabhavalkar KS. Colon
13. Kim JW, Tomita Y, Trepel J, Apolo AB. Emerging
immunotherapies for bladder cancer. Curr Opin Oncol. cancer stem cells: Potential target for the treatment of
colorectal cancer. Cancer Biol Ther. 2019;20(8):1068-1082.
2015;27(3):191-200.
doi: 10.1080/15384047.2019.1599660
doi: 10.1097/cco.0000000000000177
25. Ma Z, Zhang C, Liu X, et al. Characterisation of a
14. Song D, Powles T, Shi L, Zhang L, Ingersoll MA, Lu YJ.
Bladder cancer, a unique model to understand cancer subpopulation of CD133(+) cancer stem cells from
immunity and develop immunotherapy approaches. Chinese patients with oral squamous cell carcinoma. Sci
J Pathol. 2019;249(2):151-165. Rep. 2020;10(1):8875.
doi: 10.1038/s41598-020-64947-9
doi: 10.1002/path.5306
26. Du L, Wang H, He L, et al. CD44 is of functional
15. Patel VG, Oh WK, Galsky MD. Treatment of muscle- importance for colorectal cancer stem cells. Clin Cancer Res.
invasive and advanced bladder cancer in 2020. CA Cancer J 2008;14(21):6751-6760.
Clin. 2020;70(5):404-423.
doi: 10.1158/1078-0432.Ccr-08-1034
doi: 10.3322/caac.21631
27. Chan KS, Espinosa I, Chao M, et al. Identification, molecular
16. Powles T, Rosenberg JE, Sonpavde GP, et al. Enfortumab
vedotin in previously treated advanced urothelial carcinoma. characterization, clinical prognosis, and therapeutic
targeting of human bladder tumor-initiating cells. Proc Natl
N Engl J Med. 2021;384(12):1125-1135.
Acad Sci U S A. 2009;106(33):14016-14021.
doi: 10.1056/NEJMoa2035807
doi: 10.1073/pnas.0906549106
17. Cancer Genome Atlas Research Network. Comprehensive 28. Wang KJ, Wang C, Dai LH, et al. Targeting an autocrine
molecular characterization of urothelial bladder carcinoma. regulatory loop in cancer stem-like cells impairs the
Nature. 2014;507(7492):315-322.
progression and chemotherapy resistance of bladder cancer.
doi: 10.1038/nature12965 Clin Cancer Res. 2019;25(3):1070-1086.
18. Siefker-Radtke AO, Matsubara N, Park SH, et al. Erdafitinib doi: 10.1158/1078-0432.Ccr-18-0586
versus pembrolizumab in pretreated patients with advanced 29. Li C, Du Y, Yang Z, et al. GALNT1-Mediated glycosylation
or metastatic urothelial cancer with select FGFR alterations: and activation of sonic hedgehog signaling maintains the
Cohort 2 of the randomized phase III THOR trial. Ann self-renewal and tumor-initiating capacity of bladder cancer
Oncol. 2024;35:107-111.
stem cells. Cancer Res. 2016;76(5):1273-1283.
doi: 10.1016/j.annonc.2023.10.003
doi: 10.1158/0008-5472.Can-15-2309
19. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells,
cancer, and cancer stem cells. Nature. 2001;414(6859):105-111. 30. Ooki A, VandenBussche CJ, Kates M, et al. CD24 regulates
cancer stem cell (CSC)-like traits and a panel of CSC-related
doi: 10.1038/35102167 molecules serves as a non-invasive urinary biomarker for the
detection of bladder cancer. Br J Cancer. 2018;119(8):961-970.
20. Bonnet D, Dick JE. Human acute myeloid leukemia is
organized as a hierarchy that originates from a primitive doi: 10.1038/s41416-018-0291-7
hematopoietic cell. Nat Med. 1997;3(7):730-737.
31. Su Y, Qiu Q, Zhang X, et al. Aldehyde dehydrogenase 1
doi: 10.1038/nm0797-730 A1-positive cell population is enriched in tumor-initiating
cells and associated with progression of bladder cancer.
21. Verma P, Shukla N, Kumari S, Ansari MS, Gautam NK,
Patel GK. Cancer stem cell in prostate cancer progression, Cancer Epidemiol Biomarkers Prev. 2010;19(2):327-337.
metastasis and therapy resistance. Biochim Biophys Acta Rev doi: 10.1158/1055-9965.Epi-09-0865
Cancer. 2023;1878(3):188887.
32. Zhang Y, Zhang X, Huang X, et al. Tumor stemness score
doi: 10.1016/j.bbcan.2023.188887 to estimate epithelial-to-mesenchymal transition (EMT)

Volume 1 Issue 1 (2024) 44 doi: 10.36922/mi.2377